Search company, investor...

ESTECH

estech.com

Founded Year

2009

Stage

Acquired | Acquired

Total Raised

$39.8M

Valuation

$0000 

About ESTECH

Estech, formerly Endoscopic Technologies, develops and markets a portfolio of medical devices and disposables that enable cardiac surgeons to perform a variety of minimally invasive surgical procedures, including the growing trend in minimally invasive and hybrid ablation procedures, with maximum ease of use, patient safety and clinical effectiveness. The company's product lines span three cardiac surgery disciplines, including temperature-controlled RF ablation, valve replacement and repair, and coronary artery bypass grafting.

Headquarters Location

2603 Camino Ramon Suite 100

San Ramon, California, 94583,

United States

Missing: ESTECH's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ESTECH's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

ESTECH Patents

ESTECH has filed 35 patents.

The 3 most popular patent topics include:

  • Chemical processes
  • Electrochemistry
  • Electrolysis
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/26/2021

1/11/2022

Chemical processes, Electrochemistry, Industrial gases, Electrolysis, Gas technologies

Grant

Application Date

5/26/2021

Grant Date

1/11/2022

Title

Related Topics

Chemical processes, Electrochemistry, Industrial gases, Electrolysis, Gas technologies

Status

Grant

Latest ESTECH News

electric classic Mini Beijing Estech Technology

Jun 6, 2022

June 5, 2022 A new electric car manufacturer has recently entered the Chinese market and would already resurrect one of the most popular small cars ever, the Mini, in electrical terms. Car News China on the basis of the information provided by Carscoops . Little is known about Beijing Estech Technology in Beijing, which is behind the project, but it is rumored that it is also financially supported by two other manufacturers, IAT Automobile Technology and Karlmann King. We’re also groping in the dark about a car featured in the company’s air-conditioned images in the local press, which is clearly the Minire’s hair, which produced more than five million copies in total between 1959 and 2000. The two-door city car, if not elsewhere, is certainly familiar to many from Mr. Bean: As with the classic Mini, features such as round headlights, fog lights and a (presumably chrome) bumper are easy to see. The retro-bumped antenna is also hard to confuse with the other, as the headlights, like the headlights, have round-shaped exterior mirrors, chrome wipers and a small luggage compartment, as well as a classic fuel cap on the back, but this time probably hiding the electrical connector. What may differ from the original design is its wheelbase, which promises to be longer to accommodate four passengers in the interior, despite the electric drive. Although most of the technical parameters have not yet been revealed, the portal knows that an electric motor will drive the front axle and the battery pack will be located inside the floor. The most iconic small car can be counterfeited by the Chinese Share a photo:

ESTECH Frequently Asked Questions (FAQ)

  • When was ESTECH founded?

    ESTECH was founded in 2009.

  • Where is ESTECH's headquarters?

    ESTECH's headquarters is located at 2603 Camino Ramon, San Ramon.

  • What is ESTECH's latest funding round?

    ESTECH's latest funding round is Acquired.

  • How much did ESTECH raise?

    ESTECH raised a total of $39.8M.

  • Who are the investors of ESTECH?

    Investors of ESTECH include AtriCure, Silicon Valley Bank, NXT Capital, Telegraph Hill Partners, Saints Capital and 7 more.

  • Who are ESTECH's competitors?

    Competitors of ESTECH include NeoChord, Angel Medical Systems, GENICON, Cyberheart, Dextera Surgical and 12 more.

Compare ESTECH to Competitors

Angel Medical Systems Logo
Angel Medical Systems

Angel Medical Systems develops the AngelMed Guardian system, an implantable cardiac monitoring and alerting system that is designed to warn cardiac patients of potentially life-threatening heart conditions. The AngelMed Guardian System heart monitor is designed to track changes in the heart's electrical signal from a standard pacemaker lead, identify the signature of acute thrombotic occlusions when they occur, and then alert the patient directly to seek medical attention. The device is being studied in high risk heart patients who do not qualify for an ICD, but who have had a STEMI, NSTEMI or unstable angina in their recent past. The company was founded in 2001 and is based in Eatontown, New Jersey.

A
Arbor Surgical Technologies

Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.

NeoChord Logo
NeoChord

NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. The company was founded in 2007 and is based in Minneapolis, Minnesota.

S
Softscope Medical Technologies

Softscope Medical Technologies is developing a medical technology designed to facilitate the performance of endoscopic procedures.

N
Neurosonix

NeuroSonix is an Israeli medical device company targeting the market of cerebral embolic protection during cardiac surgical and other minimally invasive procedures. NeuroSonix has conceived, developed and patented a technology and medical devices for the prevention of acute cerebral embolism during open-heart cardiac surgery as well as other invasive and minimally-invasive procedures. The company's technology, which is based on ultrasound, aims to enable a non-invasive deflection of embolic material flowing inside the body, away from the cerebral arteries. This new ultrasonic modality aims to reduce the embolic load on the patient's brain. The first product developed by the company is the EmBlocker"ž, intended to provide protection from acute cerebral embolism during cardiac surgical procedures. The Protection Collar, the company's second product, is intended for embolic protection during minimally-invasive procedures and Cath-lab practice.

A
Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment. Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.